0RIS

Targovax Asa Notizie

Acquistare
Vendere
Le migliori offerte per accedere ai dati in tempo reale
Borsa di Londra
Sottoscrizione Mensile
per soli
22,17 €
Book Borsa di Londra
Sottoscrizione Mensile
per soli
59,13 €
World Guru
Sottoscrizione Mensile
per soli
126,50 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Targovax Asa 0RIS Londra Azione Ordinaria NO0010689326 TARGOVAX ORD SHS
  Variazione Variazione % Quotazione Attuale Ora
0,00 0,0% 15,98 01:00:00
Apertura Min Max Prezzo di chiusura Chiusura
15,98 15,98
quotazione »

Ultime notizie

Data Ora Fonte Titolo
24/11/202007:16PRNUSTargovax demonstrates encouraging survival data for..
24/11/202007:15PRNUSTargovax demonstrates encouraging survival data for..
17/11/202007:27PRNUSTargovax to present at Bryan Garnier & Co Virtual European..
09/11/202016:52PRNUSTargovax announces poster at the 2020 Society for..
05/11/202010:55PRNUSTargovax ASA: third quarter 2020 results
05/11/202007:37PRNUSTargovax ASA: third quarter 2020 results
28/10/202007:53PRNUSTargovax announces formation of new Scientific Advisory..
28/10/202007:51PRNUSTargovax announces formation of new Scientific Advisory..
19/10/202007:17PRNUSTargovax announces accepted abstract at SITC
19/10/202007:15PRNUSTargovax announces accepted abstract at SITC
13/10/202007:28PRNUSTargovax announces that the ONCOS-102 and durvalumab trial..
13/10/202007:24PRNUSTargovax announces that the ONCOS-102 and durvalumab trial..
12/10/202007:56PRNUSTargovax granted European Patent for ONCOS-102 in..
12/10/202007:51PRNUSTargovax granted European Patent for ONCOS-102 in..
22/6/202007:19PRNUSTargovax's ONCOS-102 Mesothelioma 12-month Data Powerfully..
04/6/202008:19PRNUSTargovax Enters Collaboration With Leidos to add Checkpoint..
04/6/202008:16PRNUSTargovax Enters Collaboration With Leidos to add Checkpoint..
14/5/202009:08PRNUSTargovax Announces That the ONCOS-102 and Durvalumab..
14/5/202009:04PRNUSTargovax Announces That the ONCOS-102 and Durvalumab..
06/5/202007:22PRNUSTargovax Announces That Abstract on Interim Phase I Clinical..
06/5/202007:20PRNUSTargovax Announces That Abstract on Interim Phase I Clinical..
04/5/202007:23PRNUSTargovax Releases Update for Mesothelioma Trial Combining..
04/5/202007:20PRNUSTargovax Releases Update for Mesothelioma Trial Combining..
30/4/202007:20PRNUSTargovax ASA Appoints Dr Victor Levitsky as Chief Scientific..
30/4/202007:14PRNUSTargovax ASA Appoints Dr Victor Levitsky as Chief Scientific..
22/4/202007:13PRNUSTargovax and Valo Therapeutics Enter Collaboration to..
22/4/202007:11PRNUSTargovax and Valo Therapeutics Enter Collaboration to..
03/4/202007:23PRNUSTargovax ASA Announces Proposed New Chairman of the Board
03/4/202007:21PRNUSTargovax ASA Announces Proposed New Chairman of the Board
11/3/202007:10PRNUSTargovax ASA: Fourth Quarter 2019 Results
11/3/202007:09PRNUSTargovax ASA: Fourth Quarter 2019 Results
03/3/202007:17PRNUSTargovax Announces Completed Enrollment in the ONCOS-102..
03/3/202007:14PRNUSTargovax Announces Completed Enrollment in the ONCOS-102..
21/1/202017:18PRNUSTargovax Announces Encouraging Data in Mesothelioma Study..
21/1/202017:16PRNUSTargovax Announces Encouraging Data in Mesothelioma Study..
08/1/202013:07PRNUSUpdated Press Release: Targovax and IOVaxis Therapeutics..
08/1/202013:04PRNUSUpdated Press Release: Targovax and IOVaxis Therapeutics..
Accedi alle altre notizie sul titolo »
La tua Cronologia
LSE
0RIS
Targovax A..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20201127 03:56:30